Treatment of preterm birth

doi:10.3877/cma.j.issn.2095-3259.2018.04.007

Abstract

Abstract:

Preterm birth is a major cause of neonatal death and complications worldwide. The complications of premature infants bring a heavy burden on families and society. Therefore, it catches the focus of attentions in perinatal medicine. In recent years, with the improvement of medical level, the treatment and monitoring measures for preterm birth have been continuously improved, and the perinatal outcome has been effectively improved. This paper discusses the treatment of preterm birth.

Key words: Preterm birth, Tocolytics, Glucocorticoid, Magnesium sulfate, Antibiotics

Yanhong Chen, Dunjin Chen. Treatment of preterm birth[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2018, 07(04): 221-224.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhckjjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3259.2018.04.007

https://zhckjjdzzz.cma-cmc.com.cn/EN/Y2018/V07/I04/221

References 25

[1]	Committee on Practice Bulletins-Obstetrics. Management of preterm labor. Practice Bulletin No.171. American College of Obstetricians and Gynecologists [J]. Obstet Gynecol, 2016, 128(4): e155-e164.
[2]	Loïc S, Marie-Victoire S, Pierre-Yves A, et al. Prevention of spontaneous preterm birth: Guidelines for clinical practice from the French College of Gynaecologists and Obstetricians [J]. Eur J Obstet Gynecol Reprod Biol, 2016, 30(210): 217-224.
[3]	Vogel JP, Chawanpaiboon s, Watananirun K, et al. Global regional and national levels and trends of preterm birth rates for 1990 to 2014: protocol for development of World Health Organization estimates [J]. Reprod Health, 2016, 13(1): 76.
[4]	Kenyon S, Pike K, Jones DR, et al. Childhood outcomes after prescription of antibiotics with spontaneous preterm labour: 7-year follow-up of the ORACLE II trial [J]. Lancet, 2008, 372(9646): 1319-1327.
[5]	Witter FR, Zimmerman AW, Reichmann JP, et al. In utero beta 2 adrenergic agonist exposure and adverse neurophysiologic and behavioral outcomes [J]. Am J Obstet Gynecol, 2009, 201(6): 553-559.
[6]	World Health Organization.WHO recommendations on interventions to improve preterm birth outcomes. Geneva: World Health Organization [EB/OL]. [2015-8-15]. URL
[7]	RCOG. Tocolysis for women in preterm labour, Green-top Guildline No.1b, London, RCOG[EB/OL]. [2014-024)5]. URL
[8]	Sood BG, Lulic-Botica M, Holzhausen KA, et al. The risk of necrotizing enterocolitis after indomethacin tocolysis [J]. Pediatrics, 2011, 128(1): e54-e62.
[9]	Soraisham AS, Dalgleish S, Singhal N. Antenatal indomethacin tocolysis is associated with an increased need for surgical ligation of patent ductus arteriosus in preterm infants [J]. J Obstet Gynaecol Can, 2010, 32(5): 435-442.
[10]	Han S, Crowther CA, Moore V. Magnesium maintenance therapy for preventing preterm birth after threatened preterm labour [J]. Cochrane Database Syst Rev, 2010, (7): CD000940.
[11]	Sotiriadis A, Tsiami A, Papatheodorou S, et al. Neurodevelopmental outcome after a single course of antenatal steroids in children born preterm: a systematic review and meta analysis [J]. Obstet Gynecol, 2015, 125(6): 1385-1389.
[12]	Periviable Birth. Obstetric Care Consensus No. 3. American College of Obstetricians and Gynecologists [J]. Obstet Gynecol, 2015, 126: e82-e94.
[13]	American College of Obstetricians and Gynecologists. Antenatal Corticosteroid Therapy for Fetal Maturation. Committee Opinion No. 677 [J]. Obstet Gynecol, 2016, 128: e187-e194.
[14]	Antenatal corticosteroids revisited: repeat courses [J]. NIH Consens Statement, 2000, 17(2): 1-18.
[15]	Gyamfi-Bannerman C, Thom EA, Blackwell SC, et al. Antenatal betamethasone for women at risk for late preterm delivery. NICHD Maternal-Fetal Medicine Units Network [J]. N Engl J Med, 2016, 374(14): 1311-1320.
[16]	Crowther CA, McKinlay CJ, Middleton P, et al. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes [J]. Cochrane Database of Systematic Reviews, 2015, (7): CD003935.
[17]	中华医学会妇产科学分会产科学组，早产临床诊断与治疗指南 [J]. 中华妇产科杂志，2014, 49(7): 481-485.
[18]	Society for Maternal-Fetal Medicine(SMFM). Publications committee. Implementation of the use of antenatal corticosteroids in the late preterm birth period in women at risk for preterm delivery [J]. Am J Obstet Gynecol, 2016, 215(2): B13-B15.
[19]	Shields A, Thomson M, Winter V, et al. Repeated courses of antenatal corticosteroids have adverse effects on aspects of brain development in naturally delivered baboon infants [J]. Pediatr Res, 2012, 71(6): 661-667.
[20]	American College of Obstetricians and Gynecologists Committee on Obstetric Practice, Society for Maternal-Fetal Medicine.Committee Opinion No.455: Magnesium sulfate before anticipated preterm birth for neuroprotection [J]. Obstet Gynecol, 2010, 115: 669-671.
[21]	SOGC Clinical Practice Guideline. Magnesium sulphate for fetal neuroprotection [J]. J Obstet Gynecol Can, 2011, 33(5): 516-529.
[22]	Marret S, Doyle LW, Crowther CA, et al. Antenatal magnesium sulphate neuroprotection in the preterm infant [J]. Semin Fetal Neonatal Med, 2007, 12(4): 311-317.
[23]	American College of Obstetricians and Gynecologists.Practice Bulletin No.159: Management of Preterm Labor [J]. Obstet Gynecol, 2016, 127(1): 29-38.
[24]	Kenyon S, Boulvain M, Neilson JP. Antibiotics for preterm rupture of membranes [J]. Cochrane Database of Systematic Reviews, 2010, 8: CD001058.
[25]	Kenyon SL, Taylor DJ, Tarnow-Mordi W. Broadspectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial [J]. Lancet, 2001, 357(926): 979-988.

Please choose a citation manager

Content to export